Abstract:Alzheimer's disease (AD) has an insidious onset and lacks clear early diagnostic markers, and by the time overt dementia symptoms appear, the disease is already in the mid-to-late stages. The search for early diagnostic markers of AD may open a critical window for Alzheimer's treatment and facilitate early intervention to slow the progression of AD. In this study, we aimed to explore the imaging markers for early diagnosis of AD through the combined application of structural magnetic resonance imaging (sMRI), resting-state functional magnetic resonance imaging (rs-fMRI), and 1 H-magnetic resonance spectroscopy ( 1 H-MRS) multimodal magnetic resonance imaging (MRI) techniques at the animal experimental level, with the aim to provide a certain reference for early clinical diagnosis of AD. First, sMRI scans were performed on 4-month-old amyloid beta precursor protein/presenilin 1 (APP/PS1) transgenic AD model mice and wild type mice of the same litter using a 7.0 T animal MRI scanner to analyze the differential brain regions with structural changes in the gray matter of the brain by voxel-based morphometry (VBM). Next, rs-fMRI scans were performed to analyze the differential brain regions between groups for local spontaneous brain activity and functional connectivity (FC) between brain regions. Finally, 1 H-MRS scans were performed to quantify and analyze intergroup differences in the relative concentrations of different metabolites within regions of interest (cortex and hippocampus). Compared with wild type mice, the volume of the left hippocampus, and right olfactory bulb of APP/PS1 transgenic AD model mice were reduced, the functional activity of the bilateral hippocampus, right piriform cortex and right caudate putamen was reduced, the functional network connectivity of the hippocampus was impaired, and the relative content of N-acetylaspartate (NAA)in the hippocampus was decreased. In addition, this study found that imaging changes in olfactory-related brain regions were closely associated with AD diagnosis, and these findings may provide some reference for the early diagnosis of AD.

Research progress in multimodal imaging analysis of Alzheimer's disease

Neuroimaging in the diagnosis and differentiation of Alzheimer′s disease

Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease

Advances in MRI in diagnosis of early-stage Alzheimer’sdisease

Integrated Positron Emission Tomography/Magnetic Resonance Imaging in Clinical Diagnosis of Alzheimer’s Disease

Biomarker Research of Preclinical Alzheimer’s Disease and MCI Based on Neuroimage Techniques

Multimodal Identification of Alzheimer's Disease: A Review

The Advancement in Alzheimer Disease of Imaging Diagnosis

Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI.

PET and MRI Imaging in Alzheimer’s Disease：Potential Mechanisms and Findings

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

Progress of Clinical Laboratory Tests and Molecular Imaging for Diagnosis of Alzheimer's Disease

Prediction of Alzheimer's Disease Progression Based on Magnetic Resonance Imaging

Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future

Applications and Challenges of Machine Learning Methods in Alzheimer's Disease Multi-Source Data Analysis

Advances of Molecular Imaging Probes for the Diagnosis of Alzheimer's Disease.

Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging

Preliminary study on early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice using multimodal magnetic resonance imaging

PET/MR Imaging: New Frontier in Alzheimer's Disease and Other Dementias.

PET/MR Imaging: New Frontier in Alzheimer's Disease and Other Dementias

Molecular Imaging of Alzheimer Disease